Elsevier,
The Lancet Regional Health - Europe, Volume 25, February 2023
This Viewpoint supprts SDG 3 by focusing on the health and wellbeing of people with disabilities in Europe and discussing inclusive health sectors, which could aid the protection of the human rights of people with disabilities and the promotion of their health.
Elsevier,
The Lancet Regional Health - Western Pacific, Volume 31, February 2023
This Article supports SDGs 3 and 10 by evaluating whether provision of a cash transfer to children and adolescents would improve their access to health and education resources, by removing financial barriers to these resources. The programme was successful in this regard; eg, beneficiaries were twice as likely as non-beneficiaries to use rehabilitation services and attend school.
LexisNexis Legal & Professional
LexisNexis Legal & Professional hosted a panel discussion, Lawyers and the Climate Emergency, in partnership with the International Law Book Facility (ILBF).
Elsevier,
The Lancet Global Health, Volume 11, Issue 3, March 2023, Pages e466-e474
This Health Policy paper supports SDG 3 by analysing the current national action plans for antimicrobial resistance adopted by UN member states at the 2015 World Health Assembly; the authors identify gaps in key domains and highlight opportunities to facilitate sustainable delivery and operationalisation of national action plans.
Elsevier,
Experimental Neurology, Volume 360, February 2023
This review discusses the role of the endocannabinoid system in pain management, particularly in the context of chronic pain co-morbid with Alzheimer's disease (AD), highlighting the prevalence of chronic pain among AD patients, the limitations of current treatments, and the need for further research and future directions.
Elsevier,
Behavioural Brain Research, Volume 437, 2 February 2023
This case report discusses the comparison of circulating levels of vascular endothelial growth factor (VEGF) and platelets between Alzheimer's disease (AD) patients and healthy older adults, revealing lower VEGF levels and a trend towards reduced platelet numbers in AD patients, indicating potential modifications in angiogenic factors associated with the disease.
Elsevier,
Behavioural Brain Research, Volume 438, 13 February 2023
This article discusses the impact of early life sensorial intervention on behavioral patterns, peripheral immune-endocrine organs, corticosterone levels, and responses to NMDA-induced motor depression in male and female 3xTg-AD mice, highlighting sex and genotype differences in susceptibility to glutamatergic excitotoxicity and modulation of the neuroimmunoendocrine system in Alzheimer's disease.